ID   SYV_GEOSE               Reviewed;         880 AA.
AC   P11931;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   02-DEC-2020, entry version 111.
DE   RecName: Full=Valine--tRNA ligase;
DE            EC=6.1.1.9;
DE   AltName: Full=Valyl-tRNA synthetase;
DE            Short=ValRS;
GN   Name=valS;
OS   Geobacillus stearothermophilus (Bacillus stearothermophilus).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Geobacillus.
OX   NCBI_TaxID=1422;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3300774; DOI=10.1021/bi00383a012;
RA   Borgford T.J., Brand N.J., Gray T.E., Fersht A.R.;
RT   "The valyl-tRNA synthetase from Bacillus stearothermophilus has
RT   considerable sequence homology with the isoleucyl-tRNA synthetase from
RT   Escherichia coli.";
RL   Biochemistry 26:2480-2486(1987).
RN   [2]
RP   EDITING ACTIVITY.
RX   PubMed=182209; DOI=10.1021/bi00660a026;
RA   Fersht A.R., Kaethner M.M.;
RT   "Enzyme hyperspecificity. Rejection of threonine by the valyl-tRNA
RT   synthetase by misacylation and hydrolytic editing.";
RL   Biochemistry 15:3342-3346(1976).
RN   [3]
RP   KINETIC PARAMETERS, AND MUTAGENESIS OF PRO-47; GLY-85 AND ASP-87.
RX   PubMed=8611551; DOI=10.1021/bi960011y;
RA   Lin L., Schimmel P.;
RT   "Mutational analysis suggests the same design for editing activities of two
RT   tRNA synthetases.";
RL   Biochemistry 35:5596-5601(1996).
CC   -!- FUNCTION: Catalyzes the attachment of valine to tRNA(Val). As ValRS can
CC       inadvertently accommodate and process structurally similar amino acids
CC       such as threonine, to avoid such errors, it has a 'posttransfer'
CC       editing activity that hydrolyzes mischarged Thr-tRNA(Val) in a tRNA-
CC       dependent manner.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-valine + tRNA(Val) = AMP + diphosphate + L-valyl-
CC         tRNA(Val); Xref=Rhea:RHEA:10704, Rhea:RHEA-COMP:9672, Rhea:RHEA-
CC         COMP:9708, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57762,
CC         ChEBI:CHEBI:78442, ChEBI:CHEBI:78537, ChEBI:CHEBI:456215; EC=6.1.1.9;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=59 uM for valine {ECO:0000269|PubMed:8611551};
CC         KM=16 mM for threonine {ECO:0000269|PubMed:8611551};
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- DOMAIN: ValRS has two distinct active sites: one for aminoacylation and
CC       one for editing. The misactivated threonine is translocated from the
CC       active site to the editing site.
CC   -!- DOMAIN: The C-terminal coiled-coil domain is crucial for aminoacylation
CC       activity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC       ValS type 1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M16318; AAA22879.1; -; Genomic_DNA.
DR   PIR; A26738; SYBSVS.
DR   SMR; P11931; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004832; F:valine-tRNA ligase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006438; P:valyl-tRNA aminoacylation; IEA:UniProtKB-UniRule.
DR   CDD; cd07962; Anticodon_Ia_Val; 1.
DR   Gene3D; 1.10.287.380; -; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   Gene3D; 3.90.740.10; -; 1.
DR   HAMAP; MF_02004; Val_tRNA_synth_type1; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR002300; aa-tRNA-synth_Ia.
DR   InterPro; IPR033705; Anticodon_Ia_Val.
DR   InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR010978; tRNA-bd_arm.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   InterPro; IPR037118; Val-tRNA_synth_C_sf.
DR   InterPro; IPR019499; Val-tRNA_synth_tRNA-bd.
DR   InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR   InterPro; IPR002303; Valyl-tRNA_ligase.
DR   Pfam; PF08264; Anticodon_1; 1.
DR   Pfam; PF00133; tRNA-synt_1; 1.
DR   Pfam; PF10458; Val_tRNA-synt_C; 1.
DR   PRINTS; PR00986; TRNASYNTHVAL.
DR   SUPFAM; SSF46589; SSF46589; 1.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF50677; SSF50677; 1.
DR   TIGRFAMs; TIGR00422; valS; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE   1: Evidence at protein level;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Coiled coil; Cytoplasm; Ligase;
KW   Nucleotide-binding; Protein biosynthesis.
FT   CHAIN           1..880
FT                   /note="Valine--tRNA ligase"
FT                   /id="PRO_0000106213"
FT   COILED          809..880
FT                   /evidence="ECO:0000255"
FT   MOTIF           49..59
FT                   /note="'HIGH' region"
FT   MOTIF           525..529
FT                   /note="'KMSKS' region"
FT   BINDING         528
FT                   /note="ATP"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         47
FT                   /note="P->A: Has little effect on amino acid activation."
FT                   /evidence="ECO:0000269|PubMed:8611551"
FT   MUTAGEN         47
FT                   /note="P->G: Strong decrease in amino acid activation."
FT                   /evidence="ECO:0000269|PubMed:8611551"
FT   MUTAGEN         47
FT                   /note="P->I: Strong decrease in amino acid activation. No
FT                   effect on posttransfer editing activity."
FT                   /evidence="ECO:0000269|PubMed:8611551"
FT   MUTAGEN         85
FT                   /note="G->R: Strong decrease in amino acid activation."
FT                   /evidence="ECO:0000269|PubMed:8611551"
FT   MUTAGEN         87
FT                   /note="D->A: Strong decrease in amino acid activation. No
FT                   effect on posttransfer editing activity."
FT                   /evidence="ECO:0000269|PubMed:8611551"
SQ   SEQUENCE   880 AA;  102048 MW;  462B0AE4E38B87A2 CRC64;
     MAQHEVSMPP KYDHRAVEAG RYEWWLKGKF FEATGDPNKR PFTIVIPPPN VTGKLHLGHA
     WDTTLQDIIT RMKRMQGYDV LWLPGMDHAG IATQAKVEEK LRQQGLSRYD LGREKFLEET
     WKWKEEYAGH IRSQWAKLGL GLDYTRERFT LDEGLSKAVR EVFVSLYRKG LIYRGEYIIN
     WDPVTKTALS DIEVVYKEVK GALYHMRYPL ADGSGFIEVA TTRPETMLGD TAVAVHPDDE
     RYKHLIGKMV KLPIVGREIP IIADEYVDME FGSGAVKITP AHDPNDFEIG NRHNLPRILV
     MNEDGTMNEN AMQYQGLDRF ECRKQIVRDL QEQGVLFKIE EHVHSVGHSE RSGAVIEPYL
     STQWFVKMKP LAEAAIKLQQ TDGKVQFVPE RFEKTYLHWL ENIRHWCISR QLWWGHRIPA
     WYHKETGEIY VDHEPPKDIE NWEQDPDVLD TWFSSALWPF STMGWPDTDS PDYKRYYPTD
     VLVTGYDIIF FWVSRMIFQG LEFTGKRPFK DVLIHGLVRD AQGRKMSKSL GNGVDPMDVI
     DQYGADALRY FLATGSSPGQ DLRFSTEKVE ATWNFANKIW NASRFALMNM GGMTYEELDL
     SGEKTVADHW ILTRLNETIE TVTKLAEKYE FGERGRTLYN FIWDDLCDWY IEMAKLPLYG
     DDEAAKKTTR SVLAYVLDNT MRLLHPFMPF ITEEIWQNLP HEGESITVAP WPQVRPELSN
     EEAAEEMRML VDIIRAVRNV RAEVNTPPSK PIALYIKTKD EHVRAALLKN RAYLERFCNP
     SELLIDTNVP APDKAMTAVV TGAELIMPLE GLINIEEEIK RLEKELDKWN KEVERVEKKL
     ANEGFLAKAP AHVVEEERRK RQDYIEKREA VKARLAELKR
//
